Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Malignant Melanoma

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 79 articles: HTML format

Single Articles

August 2008
1. JACKSON AM , Mulcahy LA, Zhu XW, O'Donnell D, et al
   Tumour-mediated disruption of dendritic cell function: inhibiting the MEK1/2-p44/42 axis restores IL-12 production and Th1-generation.
   Int J Cancer. 2008;123:623-32.
   PubMed     Related articles    Abstract available
   
   
   June 2008
2. BROZYNA AA , Vanmiddlesworth L, Slominski AT
   Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. VOELTER V , Diserens AC, Moulin A, Nagel G, et al
   Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
4. DOWNING A , Yu XQ, Newton-Bishop J, Forman D, et al
   Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. VAN HOUDT IS , Sluijter BJ, Moesbergen LM, Vos WM, et al
   Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. GONG W , Zhang GM, Liu Y, Lei Z, et al
   IFN-gamma withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin alphavbeta3 signaling.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. SIESLING S , van der Aa MA, Coebergh JW, Pukkala E, et al
   Time-space trends in cancer incidence in the Netherlands in 1989-2003.
   Int J Cancer. 2008;122:2106-14.
   PubMed     Related articles    Abstract available
   
   
   April 2008
8. UENO Y , Sakurai H, Tsunoda S, Choo MK, et al
   Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. HACKER E , Muller K, Whiteman DC, Pavey S, et al
   Reduced expression of IL-18 is a marker of ultraviolet radiation-induced melanomas.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. UNTERGASSER G , Steurer M, Zimmermann M, Hermann M, et al
    The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation.
    Int J Cancer. 2008;122:1539-47.
    PubMed     Related articles    Abstract available
    
    
    
11. ROBINSON SP , Ludwig C, Paulsson J, Ostman A, et al
    The effects of tumor-derived platelet-derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI.
    Int J Cancer. 2008;122:1548-56.
    PubMed     Related articles    Abstract available
    
    
    March 2008
12. RAIMONDI S , Sera F, Gandini S, Iodice S, et al
    MC1R variants, melanoma and red hair color phenotype: A meta-analysis.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
13. LI C , Liu Z, Wang LE, Gershenwald JE, et al
    Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: A case-control study.
    Int J Cancer. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. SCHIERER S , Hesse A, Muller I, Kampgen E, et al
    Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses.
    Int J Cancer. 2008;122:219-29.
    PubMed     Related articles    Abstract available
    
    
    December 2007
15. HASUMI Y , Klosowska-Wardega A, Furuhashi M, Ostman A, et al
    Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
    Int J Cancer. 2007;121:2606-14.
    PubMed     Related articles    Abstract available
    
    
    
16. POCZA P , Suli-Vargha H, Darvas Z, Falus A, et al
    Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. HABER CL , Gottifredi V, Llera AS, Salvatierra E, et al
    SPARC modulates the proliferation of stromal but not melanoma cells unless endogenous SPARC expression is downregulated.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
18. OLSEN CM , Green AC, Zens MS, Stukel TA, et al
    Anthropometric factors and risk of melanoma in women: A pooled analysis.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
19. ROESCH A , Mueller AM, Stempfl T, Moehle C, et al
    RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. SELVAN SR , Dillman RO, Fowler AW, Carbonell DJ, et al
    Monitoring response to treatment in melanoma patients: Potential of a serum glycomic marker.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. CAYUELA A , Rodriguez-Dominguez S, Vigil E, Conejo-Mir JS, et al
    Effect of age, birth cohort and period of death on skin melanoma mortality in Spain, 1975 through 2004.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. KHOLMANSKIKH O , Loriot A, Brasseur F, De Plaen E, et al
    Expression of BORIS in melanoma: Lack of association with MAGE-A1 activation.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. VAN KEMPEN LC , Rijntjes J, Mamor-Cornelissen I, Vincent-Naulleau S, et al
    Type I collagen expression contributes to angiogenesis and the development of deeply invasive cutaneous melanoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
24. BUSCH C , Drews U, Eisele SR, Garbe C, et al
    Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. YAMASHITA M , Ino A, Kawabata K, Sakurai F, et al
    Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells.
    Int J Cancer. 2007;121:1690-6.
    PubMed     Related articles    Abstract available
    
    
    
26. MAHAJAN R , Blair A, Coble J, Lynch CF, et al
    Carbaryl exposure and incident cancer in the Agricultural Health Study.
    Int J Cancer. 2007;121:1799-805.
    PubMed     Related articles    Abstract available
    
    
    August 2007
27. SMIT DJ , Gardiner BB, Sturm RA
    Osteonectin downregulates E-cadherin, induces Osteopontin and Focal adhesion kinase activity stimulating an invasive melanoma phenotype.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
28. QUIRIN C , Mainka A, Hesse A, Nettelbeck DM, et al
    Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
29. SATZGER I , Meier A, Schenck F, Kapp A, et al
    Autoimmunity as a prognostic factor in melanoma patients treated with adjuvant low-dose interferon alpha.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
30. YU YR , Fong AM, Combadiere C, Gao JL, et al
    Defective antitumor responses in CX3CR1-deficient mice.
    Int J Cancer. 2007;121:316-22.
    PubMed     Related articles    Abstract available
    
    
    
31. PACO L , Garcia-Lora AM, Casares C, Cabrera C, et al
    Total loss of HLA class I expression on a melanoma cell line after growth in nude mice in absence of autologous antitumor immune response.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
32. MIHIC-PROBST D , Kuster A, Kilgus S, Bode-Lesniewska B, et al
    Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. RAKOSY Z , Vizkeleti L, Ecsedi S, Voko Z, et al
    EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. DUA P , Ingle A, Gude RP
    Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. MAHNKE K , Schonfeld K, Fondel S, Ring S, et al
    Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro.
    Int J Cancer. 2007;120:2723-33.
    PubMed     Related articles    Abstract available
    
    
    
36. RYU B , Kim DS, Deluca AM, Healey MA, et al
    Id1 expression is transcriptionally regulated in radial growth phase melanomas.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
37. PACKER LM , Pavey SJ, Boyle GM, Stark MS, et al
    Gene expression profiling in melanoma identifies novel downstream effectors of p14ARF.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    March 2007
38. GOLDSTEIN AM , Chaudru V, Ghiorzo P, Badenas C, et al
    Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. HANS S , Bernd-Ruediger B
    Benefit of sentinel lymphadenectomy for patients with nonulcerated cutaneous melanomas in the Breslow range between 0.76 and 1 mm: A follow-up study of 148 patients.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. JIA LJ , Wei DP, Sun QM, Jin GH, et al
    Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. KARLSSON PM , Fredrikson M
    Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: The increasing trend is broken.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. NOBEYAMA Y , Okochi-Takada E, Furuta J, Miyagi Y, et al
    Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. ANTONESCU CR , Busam KJ, Francone TD, Wong GC, et al
    L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
44. KO HM , Kang JH, Jung B, Kim HA, et al
    Critical role for matrix metalloproteinase-9 in platelet-activating factor-induced experimental tumor metastasis.
    Int J Cancer. 2007;120:1277-83.
    PubMed     Related articles    Abstract available
    
    
    
45. BAZHIN AV , Schadendorf D, Willner N, De Smet C, et al
    Photoreceptor proteins as cancer-retina antigens.
    Int J Cancer. 2007;120:1268-76.
    PubMed     Related articles    Abstract available
    
    
    
46. DELI T , Varga N, Adam A, Kenessey I, et al
    Functional genomics of calcium channels in human melanoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
47. DANIOTTI M , Vallacchi V, Rivoltini L, Patuzzo R, et al
    Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. REED MJ , Karres N, Eyman D, Cruz A, et al
    The effects of aging on tumor growth and angiogenesis are tumor-cell dependent.
    Int J Cancer. 2007;120:753-60.
    PubMed     Related articles    Abstract available
    
    
    
49. GUO J , Zhu J, Sheng X, Wang X, et al
    Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
50. KLEMKE M , Rafael MT, Wabnitz GH, Weschenfelder T, et al
    Phosphorylation of ectopically expressed L-plastin enhances invasiveness of human melanoma cells.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. ZHANG QJ , Seipp RP, Chen SS, Vitalis TZ, et al
    TAP expression reduces IL-10 expressing tumor infiltrating lymphocytes and restores immunosurveillance against melanoma.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
52. SCHITTEK B , Psenner K, Sauer B, Meier F, et al
    The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. GILLE J , Heidenreich R, Pinter A, Schmitz J, et al
    Simultaneous blockade of VEGFR-1 and VEGFR-2 activation is necessary to efficiently inhibit experimental melanoma growth and metastasis formation.
    Int J Cancer. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
54. SPANJAARD RA , Whren KM, Graves C, Bhawan J, et al
    Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
55. MORI A , Sakurai H, Choo MK, Obi R, et al
    Severe pulmonary metastasis in obese and diabetic mice.
    Int J Cancer. 2006;119:2760-7.
    PubMed     Related articles    Abstract available
    
    
    
56. WETZEL K , Struyf S, Van Damme J, Kayser T, et al
    MCP-3 (CCL7) delivered by parvovirus MVMp reduces tumorigenicity of mouse melanoma cells through activation of T lymphocytes and NK cells.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
57. PFOHLER C , Preuss KD, Tilgen W, Stark A, et al
    Mitofilin and titin as target antigens in melanoma-associated retinopathy.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
58. 
    The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
59. FATTAH OM , Cloutier SM, Kundig C, Felber LM, et al
    Peptabody-EGF: a novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells.
    Int J Cancer. 2006;119:2455-63.
    PubMed     Related articles    Abstract available
    
    
    
60. FIRESTONE RA
    Lipid-lowering agents may fight cancer by denying it LDL.
    Int J Cancer. 2006;119:2497.
    PubMed     Related articles   
    
    
    
61. ROODINK I , van der Laak J, Kusters B, Wesseling P, et al
    Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression.
    Int J Cancer. 2006;119:2054-62.
    PubMed     Related articles    Abstract available
    
    
    October 2006
62. ZHI-QIANG D , Silvia VN, Helene G, Florence V, et al
    Detection of novel quantitative trait loci for cutaneous melanoma by genome-wide scan in the MeLiM swine model.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
63. ARNDT S , Bosserhoff AK
    TANGO is a tumor suppressor of malignant melanoma.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
64. SCELO G , Boffetta P, Autier P, Hemminki K, et al
    Associations between ocular melanoma and other primary cancers: An international population-based study.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    September 2006
65. CAPOBIANCO A , Rovere-Querini P, Rugarli C, Manfredi AA, et al
    Melanoma cells interfere with the interaction of dendritic cells with NK/LAK cells.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
66. DEBNIAK T , Scott R, Masojc B, Serrano-Fernandez P, et al
    MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
67. VAN HORSSEN R , Rens JA, Brunstein F, Guns V, et al
    Intratumoural expression of TNF-R1 and EMAP-II in relation to response of patients treated with TNF-based isolated limb perfusion.
    Int J Cancer. 2006;119:1481-90.
    PubMed     Related articles    Abstract available
    
    
    
68. DEMIDEM A , Morvan D, Madelmont JC
    Bystander effects are induced by CENU treatment and associated with altered protein secretory activity of treated tumor cells: a relay for chemotherapy?
    Int J Cancer. 2006;119:992-1004.
    PubMed     Related articles    Abstract available
    
    
    July 2006
69. BLANK C , Kuball J, Voelkl S, Wiendl H, et al
    Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
    Int J Cancer. 2006;119:317-27.
    PubMed     Related articles    Abstract available
    
    
    
70. LAGE H , Aki-Sener E, Yalcin I
    High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs.
    Int J Cancer. 2006;119:213-20.
    PubMed     Related articles    Abstract available
    
    
    
71. KNIEP B , Kniep E, Ozkucur N, Barz S, et al
    9-O-acetyl GD3 protects tumor cells from apoptosis.
    Int J Cancer. 2006;119:67-73.
    PubMed     Related articles    Abstract available
    
    
    May 2006
72. POTHLICHET J , Mangeney M, Heidmann T
    Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    April 2006
73. FRANK B , Meyer P, Boettger MB, Hemminki K, et al
    ARLTS1 variants and melanoma risk.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
74. CHEN L , Sundback J, Olofsson S, Jondal M, et al
    Interference with O-glycosylation in RMA lymphoma cells leads to a reduced in vivo growth of the tumor.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
75. OKAMOTO I , Krogler J, Endler G, Kaufmann S, et al
    A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    March 2006
76. LEE EY , Williamson R, Watt P, Hughes MC, et al
    Sun exposure and host phenotype as predictors of cutaneous melanoma associated with neval remnants or dermal elastosis.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
77. POPKOV M , Rader C, Gonzalez B, Sinha SC, et al
    Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
78. PARDO M , Garcia A, Thomas B, Pineiro A, et al
    The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
79. EKMEKCIOGLU S , Ellerhorst JA, Prieto VG, Johnson MM, et al
    Tumor iNOS predicts poor survival for stage III melanoma patients.
    Int J Cancer. 2006;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: